ResearcherFujian Medical UniversityActive in the last 2 years
Yongding Wu
Matched on ORCID iD 0009-0000-4874-2589; OpenAlex author ID A5104110321. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2024: 2 papers · 2025: 4 papers
Papers 6
- SenExo-cCCT2 Reprograms Senescence Response and Anti-Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/advs.202508431↗
- Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. Co-author DOI 10.1016/j.drup.2025.101240↗
- Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy. Co-author DOI 10.1016/j.drup.2025.101292↗
- TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. Co-author DOI 10.1158/0008-5472.can-24-4784↗
- Necroptosis enhances 'don't eat me' signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis. Co-author DOI 10.1038/s41467-024-50450-6↗
- Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer. Co-author DOI 10.1186/s12943-024-02128-2↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cheng‐Yu Liao · 6 shared papers, 2024–2025 · strength 1.16
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy an… DOI 10.1016/j.drup.2025.101292↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Zuwei Wang · 6 shared papers, 2024–2025 · strength 1.16
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy an… DOI 10.1016/j.drup.2025.101292↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Shi Chen · 6 shared papers, 2024–2025 · strength 1.16
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy an… DOI 10.1016/j.drup.2025.101292↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Shun‐Cang Zhu · 5 shared papers, 2024–2025 · strength 0.97
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy an… DOI 10.1016/j.drup.2025.101292↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Chengke Xie · 5 shared papers, 2024–2025 · strength 0.96
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy an… DOI 10.1016/j.drup.2025.101292↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Haoxiang Zhang · 3 shared papers, 2025 · strength 0.60
- Paper Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy an… DOI 10.1016/j.drup.2025.101292↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Paper SenExo-cCCT2 Reprograms Senescence Response and Anti-Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Duc… DOI 10.1002/advs.202508431↗
- Hong-Yi Lin · 3 shared papers, 2024–2025 · strength 0.59
- Paper Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. DOI 10.1016/j.drup.2025.101240↗
- Paper TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. DOI 10.1158/0008-5472.can-24-4784↗
- Paper Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer. DOI 10.1186/s12943-024-02128-2↗
- Ge Li · 2 shared papers, 2025 · strength 0.41
- Ge Li · 2 shared papers, 2025 · strength 0.40
- Paper Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy an… DOI 10.1016/j.drup.2025.101292↗
- Paper SenExo-cCCT2 Reprograms Senescence Response and Anti-Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Duc… DOI 10.1002/advs.202508431↗
- Yu Pan · 2 shared papers, 2025 · strength 0.40
- Chun Zhang · 1 shared paper, 2025 · strength 0.20
- Yifeng Tian · 1 shared paper, 2025 · strength 0.20
- Huixing Chen · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.